Cancer
Malignant Cervical Neoplasm
CI-CAN-00007992Explore in graph →
Top-level506 active trials4 approved drugs14 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00007992Explore in graph →
Clinical trials
1,994 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (181)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06508307 | A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors | recruiting | Phase 1 | 21 | GONGCHU Biotechnology Co., LtdOTHER | 1 | Aug 21, 2025 | clinicaltrials |
| NCT06958068 | Sexual Health Integration in Treatment of Gynecological Oncology(SHIFT-GO) | completed | — | 324 | Medical University of SilesiaOTHER | 1 | Aug 21, 2025 |
| clinicaltrials |
| NCT03748186 | Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers | completed | Phase 1 | 136 | Sutro Biopharma, Inc.INDUSTRY | 2 | Aug 20, 2025 | clinicaltrials |
| NCT07130240 | Ivonescimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy Followed by Type A Hysterectomy in Stage IB2 and IIA1 Cervical Cancer | recruiting | Phase 2 | 20 | Obstetrics & Gynecology Hospital of Fudan UniversityOTHER | 1 | Aug 19, 2025 | clinicaltrials |
| NCT06036121 | A Study of ADRX-0706 in Select Advanced Solid Tumors | active not recruiting | Phase 1 | 144 | Adcentrx TherapeuticsINDUSTRY | 2 | Aug 17, 2025 | clinicaltrials |
| NCT06398938 | Evaluation of Ultraaccelerated High Dose Rate Intrauterine Interventional Radiotherapy(EROS3) | recruiting | — | 129 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Aug 15, 2025 | clinicaltrials |
| NCT07120529 | Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective Multicenter Non-inferiority Study Comparing Overall and Progression-free Survival.(MOOSE) | recruiting | — | 300 | Medical University of SilesiaOTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT07121543 | Biological Drivers of Cervical Cancer and Side Effects From Radiation Therapy | recruiting | — | 20 | University of California, San DiegoOTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT04016389 | FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery | recruiting | N/A | 31 | University Health Network, TorontoOTHER | 2 | Aug 12, 2025 | clinicaltrials |
| NCT05057013 | A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours | active not recruiting | Phase 1 / Phase 2 | 81 | Cancer Research UKOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT04092257 | HPV-Based Screen-and-Treat Demonstration Project in Lilongwe | completed | N/A | 1,250 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT06751030 | Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria | recruiting | — | 1,500 | Emory UniversityOTHER | 1 | Aug 6, 2025 | clinicaltrials |
| NCT07104149 | Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer | recruiting | Phase 2 | 29 | The First Affiliated Hospital of Zhengzhou UniversityOTHER | 1 | Aug 5, 2025 | clinicaltrials |
| NCT03728881 | Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial(PRIMAVERA) | completed | Phase 3 | 1,240 | National Cancer Institute (NCI)NIH | 1 | Aug 3, 2025 | clinicaltrials |
| NCT06048367 | Carbon Nanoparticle-Loaded Iron [CNSI-Fe(II)] in the Treatment of Advanced Solid Tumor(CNSI-Fe(II)) | completed | Phase 1 | 19 | Sichuan Enray Pharmaceutical Sciences CompanyOTHER | 1 | Aug 3, 2025 | clinicaltrials |
| NCT00092534 | Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)(FUTURE II) | completed | Phase 3 | 12,167 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Aug 1, 2025 | clinicaltrials |
| NCT04458597 | Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus. | completed | N/A | 23 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT06691776 | Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)(FASCINATE) | recruiting | N/A | 100 | The Netherlands Cancer InstituteOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT06197802 | Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women | active not recruiting | — | 392 | Xiamen UniversityOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT06243666 | Long-term Effectiveness and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in Preadolescent Girls | active not recruiting | — | 2,188 | Xiamen UniversityOTHER | 1 | Jul 31, 2025 | clinicaltrials |
| NCT06967740 | Epidemiological Factors and Optimization of Conservative Approaches to Precancerous Lesions of Female Reproductive Organs | recruiting | — | 200 | Nikola JanovskaOTHER_GOV | 1 | Jul 31, 2025 | clinicaltrials |
| NCT03104699 | A Study of AGEN2034 in Advanced Tumors and Cervical Cancer | completed | Phase 1 / Phase 2 | 211 | Agenus Inc.INDUSTRY | 9 | Jul 30, 2025 | clinicaltrials |
| NCT03444376 | The Combination of GX-188E Vaccination and Pembrolizumab in Patients With HPV 16 and/or 18+ Advanced Cervical Cancer | completed | Phase 1 / Phase 2 | 65 | Genexine, Inc.INDUSTRY | 1 | Jul 30, 2025 | clinicaltrials |
| NCT07092696 | Induction Immunotherapy Combined With Chemotherapy Followed by Concurrent Chemoradiotherap and Immunotherapy for Cervical Cancer | recruiting | Phase 2 | 34 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jul 30, 2025 | clinicaltrials |
| NCT07093593 | Emergence of Bacterial Resistance to Antibiotics in the Digestive Microbiota of Patients Treated With Anticancer Drugs(RAMA) | not yet recruiting | N/A | 260 | Centre Georges Francois LeclercOTHER | 0 | Jul 30, 2025 | clinicaltrials |
| NCT03086681 | Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma(ECWHCCFLACC) | completed | Phase 2 | 120 | Yong Zhang,MDOTHER | 1 | Jul 29, 2025 | clinicaltrials |
| NCT07092007 | NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer | unknown | N/A | 18 | Newish Technology (Beijing) Co., Ltd.INDUSTRY | 1 | Jul 29, 2025 | clinicaltrials |
| NCT06749847 | HPV Self-sampling in the General Population(MIRABELLE) | recruiting | N/A | 6,000 | International Agency for Research on CancerOTHER | 1 | Jul 23, 2025 | clinicaltrials |
| NCT05056402 | An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old | active not recruiting | Phase 3 | 1,382 | Xiamen UniversityOTHER | 1 | Jul 22, 2025 | clinicaltrials |
| NCT07077980 | Discovery of HPV T Cell Epitopes and Development of Multi-epitope Vaccines | not yet recruiting | — | 50 | Anhui Provincial HospitalOTHER_GOV | 1 | Jul 22, 2025 | clinicaltrials |
| NCT06771193 | Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer in Italy(RETRACE) | recruiting | — | 200 | MSD Italia S.r.l.INDUSTRY | 1 | Jul 20, 2025 | clinicaltrials |
| NCT05635123 | A Cohort Study of Uterine Malignancies | recruiting | — | 6,200 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Jul 17, 2025 | clinicaltrials |
| NCT06867445 | Minimally Invasive Pelvic Exenteration in Vaginal or Cervical Cancer Recurrence(MIPEX) | recruiting | N/A | 64 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Jul 17, 2025 | clinicaltrials |
| NCT07070687 | Transcutaneous Electrical Nerve Stimulation in Nerve-Sparing Radical Hysterectomy: Effects on Bladder Management and Quality of Life in Cervical Cancer | completed | N/A | 78 | Fudan UniversityOTHER | 1 | Jul 17, 2025 | clinicaltrials |
| NCT02140021 | Biospecimen Collection and Testing for the Prevalence of Anal Dysplasia and Anal Cancer in Patients With Cervical, Vaginal and Vulvar Dysplasia and Cancer | terminated | N/A | 409 | M.D. Anderson Cancer CenterOTHER | 1 | Jul 14, 2025 | clinicaltrials |
| NCT04116320 | Focused Ultrasound Ablation and PD-1 Antibody Blockade in Advanced Solid Tumors(AM-003) | terminated | Phase 1 | 5 | Craig L Slingluff, JrOTHER | 1 | Jul 14, 2025 | clinicaltrials |
| NCT04242199 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors | completed | Phase 1 | 182 | Incyte CorporationINDUSTRY | 5 | Jul 14, 2025 | clinicaltrials |
| NCT05427058 | Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management | recruiting | N/A | 36 | University of BrawijayaOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT05453006 | HPV Self-Sampling in Somali Women (Isbaar Project)(Isbaar) | completed | N/A | 3,367 | University of MinnesotaOTHER | 1 | Jul 10, 2025 | clinicaltrials |
| NCT05563272 | 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors(STARBURST) | terminated | Phase 2 | 11 | Telix Pharmaceuticals (Innovations) Pty LtdINDUSTRY | 1 | Jul 10, 2025 | clinicaltrials |
| NCT05086692 | A Beta-only IL-2 ImmunoTherapY Study(ABILITY-1) | recruiting | Phase 1 / Phase 2 | 115 | Medicenna Therapeutics, Inc.INDUSTRY | 7 | Jul 9, 2025 | clinicaltrials |
| NCT06232083 | A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR) | recruiting | Phase 1 | 20 | Anhui Provincial HospitalOTHER_GOV | 1 | Jul 9, 2025 | clinicaltrials |
| NCT02635360 | Pembrolizumab and Chemoradiation Treatment for Advanced Cervical Cancer | completed | Phase 2 | 94 | Linda R DuskaOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT04461678 | Clinical Trial for Registration of HPV Nucleic Acid Genotyping Assay Kit | completed | N/A | 12,230 | Becton, Dickinson and CompanyINDUSTRY | 1 | Jul 2, 2025 | clinicaltrials |
| NCT01226316 | Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules | completed | Phase 1 | 285 | AstraZenecaINDUSTRY | 10 | Jun 29, 2025 | clinicaltrials |
| NCT03357757 | Avelumab With Valproic Acid in Virus-associated Cancer(LATENT) | completed | Phase 2 | 39 | AHS Cancer Control AlbertaOTHER | 1 | Jun 26, 2025 | clinicaltrials |
| NCT07036211 | Transmission of Oncogenic HPV Infection Among Families(TREVINO) | not yet recruiting | — | 700 | Tampere University HospitalOTHER | 1 | Jun 25, 2025 | clinicaltrials |
| NCT04998318 | 1:1 Comparison of the Pocket Colposcope in Kenya | completed | N/A | 434 | Duke UniversityOTHER | 1 | Jun 24, 2025 | clinicaltrials |
| NCT06977594 | Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer | not yet recruiting | N/A | 1,000 | Seoul National University HospitalOTHER | 1 | Jun 24, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Aug 21, 2025source: clinicaltrials